David Johnson is currently Chair of Medicine and Director of Renal Medicine at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, Chair of the Queensland Statewide Renal Clinical Network, Chair of the CARI Guidelines Working Parties on Peritoneal Dialysis Adequacy and Evaluation of Renal Function, Chair of the Kidney Check Australia Taskforce, Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Founding Member of the Australasian Kidney Trials Network (based at Princess Alexandra Hospital), Founding Member of the NHMRC-endorsed Cardiovascular and Renal Centre of Clinical Research Excellence, Peritoneal Dialysis Project Manager for the ANZDATA Registry and Council Member of the International Society of Peritoneal Dialysis.
He is the principal investigator on a number of large, multi-centre randomised controlled peritoneal dialysis trials, including the balANZ and HONEYPOT trials. He has published over 280 original manuscripts in peer-reviewed journals and presented over 240 abstracts at national and international scientific meetings. He has won numerous research awards for his clinical and basic science studies in the areas of peritoneal dialysis outcomes, cardiovascular risk factor modification in uraemia, renal transplantation, dialysis unit infection control, treatment of acute renal failure and mechanisms of progressive chronic kidney disease. In 2005, he was awarded the TJ Neale Award by the Australian and New Zealand Society of Nephrology for “outstanding contributions to nephrologic science.”
Professor David Johnson
MB BS (Hons) (Qld), PhD (Syd), FRACP
|